Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
Acquired. Crinetics Pharmaceuticals was acquired: the merger closed on Sep 1, 2026 and CRNX was delisted. The data below is from before the deal. Read the filing
Follow CRNX by emailGet an email when CRNX reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.
We send one confirmation email first. Only emails about CRNX, unsubscribe in one click. Privacy
📄 Latest SEC Filings in Plain English
Sep 1, 2026 ·
Deal Crinetics completed its merger with Parent, with aggregate consideration of about $10.0 billion funded by cash on hand and term loan borrowings. Shareholders received the Merger Consideration, the stock was delisted from Nasdaq, and all directors resigned. Form 8-K · SEC filing
Aug 28, 2026 ·
Shareholder vote Shareholders approved the Vertex merger agreement, with 79,240,098 votes for and 13,618 against, and the merger is expected to close on or about September 1, 2026. A non-binding vote on merger-related executive compensation failed, with 44,803,403 votes against. Form 8-K · SEC filing
Aug 19, 2026 ·
Legal Crinetics is supplementing its merger proxy with additional disclosures to address three shareholder complaints and several demand letters over the Vertex merger, while denying the allegations. The special meeting is set for August 28, 2026, and the board still recommends voting FOR the merger. Form 8-K · SEC filing
Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CRNX and every other ticker you follow. Card required, cancel anytime.
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.